nabu.science
MethodologyAboutContact

 

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-A8A7DE49·Framework v5.9·Pipeline v0.4·Evaluated 08 Oct 2026·OECD: 3.2 Clinical medicine·Subfield: Neurology·Basis: Full text·Type: Systematic review

Impact of Apolipoprotein E4 on blood-brain barrier integrity in target replacement murine models: a systematic review and meta-analysis.

Laing et al.Laing, Fialova, Wardlaw et al.·2026·Alzheimer's research & therapy·10.1186/s13195-026-02018-3 ↗

Primary claim

APOE4 mice showed a consistent reduction in CBF associated with APOE4 genotype (SMD = -2.87, 95% CI: -5.14 to -0.604, df = 2.66)

Tentative · three heterogeneous studies with limited RVE degrees of freedom do not establish consistency across models
In brief

A focused synthesis maps APOE4-related vascular dysfunction in humanised mice, but inconsistent study accounting prevents the pooled conclusions from being fully trusted.

ReliabilityCaveats4 of 4 checks completeRead the 2 entries ↓
Abstract

BACKGROUND: The E4 variant of Apolipoprotein E (APOE) is a primary genetic susceptibility risk factor for late-onset Alzheimer's disease and has been implicated in cerebrovascular dysfunction. Preclinical mouse models are widely used to study APOE4, but cohesive understanding of APOE's role is still inconsistent and lacking. The aim of this study was to systematically review and synthesise evidence from preclinical mouse studies assessing APOE4 related effects on blood-brain barrier (BBB) integrity, vascular morphology and cerebral blood flow (CBF). MAIN: A systematic search of MEDLINE, Embase, Scopus, and Web of Science was conducted (March-April 2025). Eligible studies included transgenic APOE-targeted replacement or knock-in mice reporting vascular outcomes (cerebral blood flow, blood brain barrier permeability, vascular measures). Risk of bias was assessed using SYRCLE and reporting quality with CAMARADES. Random-effects meta-analyses were conducted (where sufficient data was available), otherwise findings were narratively synthesised. Eighteen studies met inclusion. Outcome measures varied widely, including diverse approaches to CBF measurement (e.g. arterial spin labelling, autoradiography, DSC-MRI), immunohistochemical measures (e.g. collagen-IV, laminin, CD31), and diverse approaches to measurement of BBB leakage (e.g. fibronectin, fibrinogen, gadolinium-based ktrans). Seven studies contributed to meta-analysis: APOE4 mice showed a consistent reduction in CBF associated with APOE4 genotype (SMD = -2.87, 95% CI: -5.14 to -0.604, df = 2.66), and a negative non-significant trend towards reduced vascular morphology expression. Narrative synthesis identified three key mechanistic pathways linking APOE4 to vascular dysfunction: (i) insulin resistance and PI3K/AKT-mTOR signalling, (ii) Cyclophilin A-NFκB-MMP9 activation, and (iii) occludin/ECM remodelling. Risk of bias assessment revealed frequent shortcomings in randomisation, blinding, and sample size justification.

CONCLUSIONS: Preclinical evidence demonstrates that APOE4 drives alterations in vascular functioning primarily through involvement with pathways related to vascular metabolism, ECM remodelling and BBB leakage. However, heterogeneity in the model (e.g. age, sex, techniques), restricts direct comparability across studies. As such, standardisation or clarification of methodological approaches are necessary for rigorous assessment in the future.

Key Claims

Primary finding · Tentative

APOE4 mice showed a consistent reduction in CBF associated with APOE4 genotype (SMD = -2.87, 95% CI: -5.14 to -0.604, df = 2.66)

three heterogeneous studies with limited RVE degrees of freedom do not establish consistency across models

Abstract; Results—Cerebral Blood Flow; Figure 2
Quote verified
Secondary · Tentative

A random-effects meta-analysis (k = 6) showed a negative but non-significant trend toward reduced vascular morphology markers in APOE4 versus APOE3 mice

a small heterogeneous marker synthesis has unresolved five-versus-six study accounting

Results—Vascular Morphology; Figure 3
Quote verified
Secondary · Tentative

Narrative synthesis identified three key mechanistic pathways linking APOE4 to vascular dysfunction

heterogeneous narrative studies identify associations but do not establish integrated causal pathways

Abstract; Results—Narrative Summary; Figure 4
Quote verified
Secondary · Tentative

Preclinical evidence demonstrates that APOE4 drives alterations in vascular functioning primarily through involvement with pathways related to vascular metabolism, ECM remodelling and BBB leakage

causal framing exceeds the small heterogeneous and largely narrative preclinical evidence base

Abstract—Conclusions; Conclusion
Quote verified

Derived from the full evaluation — not a separate score.

Strengths · Limitations

Strengths

#contribution

Focused synthesis of vascular APOE4 evidence

The review integrates CBF, vascular morphology, BBB leakage, and mechanistic findings within humanised APOE mouse models, giving the field a focused evidence map.

↳ Abstract; Results—Study Outcomes and APOE4 Contributions to BBB Destabilisation

#methodological rigour

Registered and structured review methods

The protocol and search were registered, four databases were searched, and screening and outcome extraction used independent reviewers. SYRCLE and CAMARADES were used to characterise bias and reporting quality.

↳ Methods—Identification and Search Strategy, Study Selection and Data Extraction, and Risk of Bias

#application pathway

Actionable preclinical research agenda

The Discussion identifies longitudinal, cell-specific, and standardised studies as next steps and organises future investigation around three mechanistic axes.

↳ Discussion and Future Perspectives; Figure 4

Limitations

#methodological rigour

Included-study accounting is internally inconsistent

Results reports 18 included studies, Table 3 lists 21, and Discussion reports 22 studies assessed for quality. This uncertainty affects confidence in both the evidence map and the risk-of-bias summary.

↳ Results—Literature Retrieval and Quality Assessment; Table 3; Discussion, paragraph 2

#reporting

Morphology synthesis composition remains unclear

Results describes a six-study morphology meta-analysis, while Figure 3 says five studies, and the marker-to-study descriptions do not consistently align with Table 2. The pooled estimate therefore cannot be tracked confidently from the article.

↳ Table 2; Results—Vascular Morphology; Figure 3 caption

#positioning

Conclusions exceed pooled evidence certainty

The conclusion describes consistent pathogenic vascular-morphology alterations even though the pooled morphology estimate is non-significant, while the CBF estimate rests on three studies with limited RVE degrees of freedom.

↳ Results—Cerebral Blood Flow and Vascular Morphology; Figures 2–3; Conclusion

Does this match your read? Add your assessment ↓

Nabu Commentary

The review’s focused scope and registered, dual-reviewer methods support a genuine contribution to APOE4 vascular research. Its methodological score is held down by unexamined heterogeneity, limited RVE degrees of freedom, and inconsistent descriptions of the studies contributing to synthesis and quality assessment. The conclusion also converts a non-significant vascular-morphology estimate and a three-study CBF analysis into stronger claims of consistent pathology than the Results support. The work is most useful as a hypothesis-generating map and research-standardisation agenda rather than definitive evidence of APOE4-driven vascular mechanisms.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.8±0.2

Contribution
3.3

The review provides a focused quantitative and narrative synthesis of APOE-related BBB, vascular-morphology, and CBF outcomes in humanised mice. Its advance is constrained by only three CBF studies, a small morphology synthesis, and uncertain accounting of the included evidence base.

Abstract; Results—Literature Retrieval, Cerebral Blood Flow, and Vascular Morphology

“Seven studies contributed to meta-analysis”

Methodological Rigour
2.4

Registration, four-database searching, dual screening and extraction, risk-of-bias assessment, and RVE provide a substantial methodological foundation. Unexplored heterogeneity, limited RVE degrees of freedom, inconsistent pooled-study descriptions, and conclusions stronger than the assessed certainty reduce the score.

Methods—Identification and Search Strategy, Study Selection and Data Extraction, and Synthesis Methods; Figures 2–3; Conclusion

“degrees of freedom were limited (2.66)”

Reporting
3.1

The PRISMA structure, tables, forest plots, and three-axis narrative make the review broadly followable. Tracking is impaired by the 18/21/22 study counts, the five-versus-six morphology discrepancy, unresolved placeholders, and conclusion language that overstates the non-significant morphology result.

Results—Literature Retrieval and Vascular Morphology; Table 3; Figure 3; Conclusion

“consistent pathogenic alterations in vascular morphology”

Positioning
2.8

The paper explains the relevance of APOE4, BBB dysfunction, and ARIA and discusses model, comparator, heterogeneity, and risk-of-bias limitations. The conclusion nevertheless characterises the framework and morphology findings more strongly than those limitations permit.

Background; Limitations; Conclusion

“the pooled estimates remain derived from a limited study base”

Reliability

Caveats4 of 4 checks


Results checkNoted
  • A random-effects meta-analysis (k = 6) showed a negative but non-significant trend toward reduced vascular morphology markers in APOE4 versus APOE3 mice: "A random-effects meta-analysis (k = 6) showed a negative but non-significant trend toward reduced vascular morphology markers in APOE4 versus APOE3 mice" (Results — Vascular Morphology) vs "Standardised mean differences (SMDs) comparing APOE4 mice vs. APOE3 mice were calculated across five studies assessing vascular morphology using IHC markers (laminin, collagen-IV, CD31)." (Figure 3 caption). The Results identify six studies whereas the figure caption identifies five, and the supplied text does not establish which study set generated the pooled estimate. → Effect on result unclear
  • Narrative synthesis identified three key mechanistic pathways linking APOE4 to vascular dysfunction: "Lin et al., 2020 [39]EFAD (5xFAD × APOE-TR; E4FAD and E3FAD lines), mixed C57BL/6 × SJL background (substrain not specified); breeders originally obtained from Dr. M. J. LaDu.n = 8/group2 monthsMale, Female[39]" (Table 1 — Lin 2020) vs "In 7-month-old E4FAD mice, mTOR hyperactivity was associated with reduced P-glycoprotein (P-gp) transport at the BBB" (Results — Insulin/mTOR Signalling). Table 1 assigns Lin 2020 an age of two months whereas the mechanistic account assigns seven months, with no information establishing whether these refer to different experimental stages or which age applies to the reported outcome. → Effect on result unclear
  • Narrative synthesis identified three key mechanistic pathways linking APOE4 to vascular dysfunction: "Thomas et al., 2017 [33]APOE3 vs. APOE4 (E3FAD vs. E4FAD)BBBBBB LeakageFibrinogen IHC (% area occupied)22 monthsCortex" (Table 2 — Thomas 2017) vs "Thomas et al. [33] identified that 8-month-old female E4FAD mice exhibited ~ 65% higher cortical fibrinogen levels and increased sodium fluorescein (NaFl) leakage compared to other groups" (Results — Occludin & ECM). The fibrinogen comparison attributed to Thomas 2017 is assigned an age of 22 months in Table 2 but eight months in the narrative, so its correct age cannot be established from the supplied text. → Effect on result unclear
  • Narrative synthesis identified three key mechanistic pathways linking APOE4 to vascular dysfunction: "Yamazaki et al., 2020 [37]APOE3 vs. APOE4BBBBasement Membrane IntegrityCollagen-IV immunofluorescence (relative intensity)22 monthsCortex" (Table 2 — Yamazaki 2020) vs "Immunofluorescence confirmed diminished collagen-IV in 8-month-old APOE4 mice." (Results — Occludin & ECM). The collagen-IV immunofluorescence result attributed to Yamazaki 2020 is assigned an age of 22 months in Table 2 but eight months in the narrative, leaving the age of the evidence used in the temporal interpretation unresolved. → Effect on result unclear
Reporting and transparencyNoted

Marker-to-study labels, model descriptions and eligibility reporting require clarification; the supplied text does not establish corrected pooled effects or changes to the mechanistic conclusions.

Conflict of interest: not stated · Preregistration: declared · Data availability: not stated · Code availability: not stated

Reference IntegrityClean

69 references in manuscript 66 of 66 checkable references found in an index 3 are books, websites or datasets — counted, but not index-checkable

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordClean

No retraction or expression of concern found in Crossref (includes Retraction Watch).

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Neurological · Alzheimer's disease and other dementias
Type of advanceSynthesis
Route to useSuggested
AdvanceConsolidates
BeneficiariesLarge
CitationsToo early
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessControlled
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The meta-analysis synthesizes controlled mouse experiments showing reduced cerebral blood flow in APOE4 mice, but no human validation or clinical testing has been performed.

From the paper
“offer a robust framework to inform translational research, including therapeutic development, biomarker discovery, and precision medicine strategies”

The conclusion names possible real-world uses of these findings in therapeutic development, biomarker discovery, and precision medicine, but does not name specific actors who would apply them.

Pathway

Drug developers and clinical researchers could target the identified mTOR, CypA-MMP9, and occludin-ECM pathways to develop BBB-protecting therapies for APOE4 carriers at risk of Alzheimer's disease.

Barrier

Mouse model findings with high heterogeneity, unclear risk of bias, and no human validation require confirmation in APOE4 carriers before informing therapeutic development.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline

    Montagne, Nation, Sagare, et al. · 2020 · Clinical medicine

    Primary claim

    Our findings suggest that breakdown of the BBB contributes to APOE4-associated cognitive decline independently of Alzheimer's disease pathology, and might be a therapeutic target in APOE4 carriers.

    Tentative
    Evidence Score
    2.7±0.2
    Reliability
    Caveats
  2. Friend or foe? Glial-vascular interactions in health and neurodegenerative disease

    McQuaid, Sewell, Montagne · 2026 · Basic medicine (neurosciences)

    Primary claim

    glial-vascular interactions within the NGVU serve as both essential physiological mechanisms and critical pathological contributors across the spectrum of NDDs.

    Tentative
    Evidence Score
    3.2±0.2
    Reliability
    Caveats
  3. Photobiomodulation restores blood-brain barrier integrity after hypoxia via endothelial von Willebrand factor modulation in a humanised tricellular transwell model

    Domocos, Bragin, Shanbhag, et al. · 2026 · Neurology and psychiatry

    Primary claim

    Hypoxia significantly reduced transendothelial electrical resistance (TEER), whereas PBM restored barrier function in endothelial monocultures and tri-cultures.

    Supported
    Evidence Score
    2.7±0.1
    Reliability
    Caveats

How the rubric works →